LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Elsevier’s 2025 Intravenous Medications
A Handbook for Nurses and Health Professionals
- 41st Edition - August 24, 2024
- Author: Shelly Rainforth Collins
- Language: English
- formats.SpiralBound ISBN:9 7 8 - 0 - 4 4 3 - 1 2 0 4 0 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 2 0 9 9 - 2
**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Pharmacology**Find the essential information you need to safely administer more than 400 in… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quote**Selected for Doody’s Core Titles® 2024 with "Essential Purchase" designation in Pharmacology**
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2025 edition are 16 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
Find the essential information you need to safely administer more than 400 intravenous drugs! For nearly 50 years, Elsevier’s Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for complete, accurate drug information in a concise, quick-access format. New to the 2025 edition are 16 monographs of the most recent IV drugs to be approved by the FDA, in addition to updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Known as the #1 IV drug handbook on the market, this annual publication is ideal for use in critical care areas, at the nursing station, in the office, and in public health and home care settings.
- Detailed monographs on more than 400 IV drugs provide an impressive breadth of coverage that goes well beyond any comparable drug reference.
- Individual monographs include the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
- Additional drug monographs are provided on the Evolve website.
- Highlighted Black Box Warnings make it easy to locate information on medications with serious safety risks.
- Blue-screened text calls attention to special circumstances not covered by Black Box Warnings.
- Dosage and dilution charts within monographs provide quick summaries of essential clinical information.
- Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
- Convenient, A-to-Z format organizes all drug monographs by generic name, allowing you to find any drug in seconds.
- Spiral binding allows the book to lie flat, leaving your hands free to perform other tasks.
- NEW! Drug monographs for 16 newly approved drugs by the FDA include the most current information.
- NEW! Updates on drug uses, interactions, precautions, alerts, and more are included throughout the guide to reflect changes to existing medications.
- NEW! Best practices guidelines for the preparation and administration of injectable drugs are provided from the National Coalition for IV Push Safety.
- Cover image
- Title page
- Table of Contents
- HOW TO USE
- HOW TO USE THIS BOOK
- Copyright
- Dedication
- PREFACE
- FORMAT AND CONTENT OF INTRAVENOUS MEDICATIONS
- KEY TO ABBREVIATIONS
- IMPORTANT IV THERAPY FACTS
- RESOURCES
- PREPARATION AND ADMINISTRATION OF INJECTABLE DRUGS
- GENERIC DRUGS: A
- A
- ABATACEPT
- ACETAMINOPHEN
- ACETAZOLAMIDE SODIUM
- ACETYLCYSTEINE INJECTION
- ACYCLOVIR
- ADENOSINE
- ADO-TRASTUZUMAB EMTANSINE
- ADUCANUMAB
- AGALSIDASE BETA
- ALBUMIN (HUMAN)
- ALDESLEUKIN
- ALEMTUZUMAB
- ALFENTANIL HYDROCHLORIDE
- ALGLUCERASE
- ALGLUCOSIDASE ALFA
- ALLOPURINOL SODIUM
- ALPHA1-PROTEINASE INHIBITOR (HUMAN)
- ALPROSTADIL
- ALTEPLASE
- AMIFOSTINE
- AMIKACIN SULFATE
- AMINOCAPROIC ACID
- AMINOPHYLLINE
- AMIODARONE HYDROCHLORIDE
- AMISULPRIDE
- AMMONIUM CHLORIDE
- AMOBARBITAL SODIUM
- AMPHOTERICIN B ■ AMPHOTERICIN B LIPID-BASED PRODUCTS
- AMPICILLIN SODIUM AND SULBACTAM SODIUM
- ANGIOTENSIN II INJECTION
- ANIDULAFUNGIN
- ANTHRAX IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
- ANIFROLUMAB
- ANTIHEMOPHILIC FACTOR (HUMAN ■ RECOMBINANT ■ RECOMBINANT [Fc FUSION PROTEIN] ■ RECOMBINANT [PEGYLATED] ■ RECOMBINANT [PEGYLATED-aucl] ■ RECOMBINANT [SINGLE CHAIN] ■ RECOMBINANT [PORCINE SEQUENCE])
- ANTIHEMOPHILIC FACTOR ■ VON WILLEBRAND FACTOR COMPLEX (HUMAN)
- ANTI-INHIBITOR COAGULANT COMPLEX
- ANTITHROMBIN III (HUMAN)
- ANTITHROMBIN RECOMBINANT
- ANTI-THYMOCYTE GLOBULIN (RABBIT)
- ANTIVENIN (LATRODECTUS MACTANS)
- ANTIVENIN (MICRURUS FULVIUS)
- ANTIVENIN CROTALIDAE POLYVALENT IMMUNE FAB (OVINE)
- APREPITANT
- ARGATROBAN
- ARGININE HYDROCHLORIDE
- ASCORBIC ACID
- ATEZOLIZUMAB
- ATRACURIUM BESYLATE
- ATROPINE SULFATE
- AVELUMAB
- AXICABTAGENE CILOLEUCEL SUSPENSION
- AZACITIDINE
- AZATHIOPRINE SODIUM
- AZITHROMYCIN
- AZTREONAM
- GENERIC DRUGS: B
- B
- BASILIXIMAB
- BELATACEPT
- BELIMUMAB
- BELINOSTAT
- BENDAMUSTINE HYDROCHLORIDE
- BENZTROPINE MESYLATE
- BEVACIZUMAB ■ BEVACIZUMAB-awwb ■ BEVACIZUMAB-bvzr
- BEZLOTOXUMAB
- BIVALIRUDIN
- BLEOMYCIN SULFATE
- BLINATUMOMAB
- BORTEZOMIB
- BOTULISM IMMUNE GLOBULIN (INTRAVENOUS HUMAN)
- BRENTUXIMAB VEDOTIN
- BREXANOLONE
- BRIVARACETAM
- BUMETANIDE
- BUPRENORPHINE HYDROCHLORIDE
- BUSULFAN
- BUTORPHANOL TARTRATE
- GENERIC DRUGS: C
- C
- C1 ESTERASE INHIBITOR (HUMAN OR RECOMBINANT)
- CAFFEINE AND SODIUM BENZOATE
- CAFFEINE CITRATE
- CALASPARGASE PEGOL-mknl
- CALCITRIOL
- CALCIUM CHLORIDE
- CALCIUM GLUCONATE
- CANGRELOR
- CARBOPLATIN
- CARFILZOMIB
- CARMUSTINE (BCNU)
- CASIMERSEN
- CASPOFUNGIN ACETATE
- CEFAZOLIN SODIUM
- CEFEPIME HYDROCHLORIDE
- CEFIDEROCOL
- CEFOTAXIME SODIUM
- CEFOTETAN DISODIUM
- CEFOXITIN SODIUM
- CEFTAROLINE FOSAMIL
- CEFTAZIDIME
- CEFTAZIDIME/AVIBACTAM
- CEFTOLOZANE/TAZOBACTAM
- CEFTRIAXONE SODIUM
- CEFUROXIME SODIUM
- CEMIPLIMAB-rwlc
- CENTRUROIDES (SCORPION) IMMUNE F(ab’)2 (EQUINE) INJECTION
- CETIRIZINE HYDROCHLORIDE
- CETUXIMAB
- CHLORAMPHENICOL SODIUM SUCCINATE
- CHLOROTHIAZIDE SODIUM
- CHLORPROMAZINE HYDROCHLORIDE
- CIPROFLOXACIN
- CISPLATIN
- CLADRIBINE
- CLEVIDIPINE BUTYRATE
- CLINDAMYCIN PHOSPHATE
- CLOFARABINE
- COAGULATION FACTOR VIIa (RECOMBINANT) RTS
- COAGULATION FACTOR X (HUMAN)
- COAGULATION FACTOR Xa (RECOMBINANT), INACTIVATED-zhzo
- COLISTIMETHATE SODIUM
- CONIVAPTAN HYDROCHLORIDE
- CONJUGATED ESTROGENS
- COPANLISIB
- CORTICORELIN OVINE TRIFLUTATE
- COSYNTROPIN
- CRIZANLIZUMAB-tmca INJECTION
- CROTALIDAE IMMUNE F(ab’)2 (EQUINE)
- CYCLOPHOSPHAMIDE
- CYCLOSPORINE
- CYSTEINE HYDROCHLORIDE
- CYTARABINE
- CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
- GENERIC DRUGS: D
- D
- DACARBAZINE
- DACTINOMYCIN
- DALBAVANCIN
- DANTROLENE SODIUM
- COMPATIBILITY
- RATE OF ADMINISTRATION
- DAPTOMYCIN
- DARATUMUMAB
- DARBEPOETIN ALFA
- DAUNORUBICIN AND CYTARABINE LIPOSOME FOR INJECTION
- DAUNORUBICIN HYDROCHLORIDE ■ DAUNORUBICIN CITRATE LIPOSOMAL INJECTION
- DECITABINE FOR INJECTION
- DEFEROXAMINE MESYLATE
- DEFIBROTIDE
- DELAFLOXACIN
- DENILEUKIN DIFTITOX
- DESMOPRESSIN ACETATE
- DEXAMETHASONE SODIUM PHOSPHATE
- DEXRAZOXANE
- DEXTRAN 1
- DEXTRAN HIGH MOLECULAR WEIGHT
- DEXTRAN LOW MOLECULAR WEIGHT
- DEXTROSE
- DIAZEPAM
- DIAZOXIDE
- Difelikefalin
- DIGOXIN
- DIGOXIN IMMUNE FAB (OVINE)
- DIHYDROERGOTAMINE MESYLATE
- DILTIAZEM HYDROCHLORIDE
- DIMENHYDRINATE
- DINUTUXIMAB
- DIPHENHYDRAMINE HYDROCHLORIDE
- DIPHTHERIA ANTITOXIN
- DIPYRIDAMOLE
- DOBUTAMINE HYDROCHLORIDE
- DOCETAXEL
- DOPAMINE HYDROCHLORIDE
- DOXAPRAM HYDROCHLORIDE
- DOXERCALCIFEROL
- DOXORUBICIN HYDROCHLORIDE ■ DOXORUBICIN HYDROCHLORIDE LIPOSOMAL INJECTION
- DOXYCYCLINE HYCLATE
- DROPERIDOL
- DURVALUMAB
- GENERIC DRUGS: E
- E
- ECULIZUMAB
- EDARAVONE
- EDETATE CALCIUM DISODIUM
- EDETATE DISODIUM
- EFGARTIGIMOD ALFA
- ELOSULFASE ALFA
- ELOTUZUMAB
- EMAPALUMAB-lzsg
- ENALAPRILAT
- ENFORTUMAB VEDOTIN-ejfv
- EPHEDRINE SULFATE
- EPINEPHRINE HYDROCHLORIDE
- EPIRUBICIN HYDROCHLORIDE
- EPOETIN ALFA ■ EPOETIN ALFA-epbx
- EPOPROSTENOL SODIUM
- EPTIFIBATIDE
- EPTINEZUMAB-jjmr
- ERAVACYCLINE
- ERIBULIN MESYLATE
- ERTAPENEM
- ERYTHROMYCIN LACTOBIONATE
- ESMOLOL HYDROCHLORIDE
- ESOMEPRAZOLE SODIUM
- ETEPLIRSEN
- ETHACRYNIC ACID
- ETOMIDATE
- ETOPOSIDE
- GENERIC DRUGS: F
- F
- FACTOR IX (HUMAN) ■ FACTOR IX COMPLEX (HUMAN)
- FACTOR IX (RECOMBINANT)
- FACTOR XIII CONCENTRATE (HUMAN)
- FAMOTIDINE
- FAM-TRASTUZUMAB DERUXTECAN-nxki
- FAT EMULSION, INTRAVENOUS
- FENOLDOPAM MESYLATE
- FENTANYL CITRATE
- FERRIC CARBOXYMALTOSE INJECTION
- FERUMOXYTOL
- FIBRINOGEN CONCENTRATE (HUMAN)
- FILGRASTIM ■ FILGRASTIM-aafi ■ FILGRASTIM-sndz
- FISH OIL TRIGLYCERIDES INJECTABLE EMULSION
- FLUCONAZOLE
- FLUDARABINE PHOSPHATE
- FLUOROURACIL
- FOLIC ACID
- FOMEPIZOLE INJECTION
- FOSAPREPITANT DIMEGLUMINE
- FOSCARNET SODIUM
- FOSNETUPITANT AND PALONOSETRON
- FOSPHENYTOIN SODIUM
- FOSPROPOFOL DISODIUM
- FUROSEMIDE
- GENERIC DRUGS: G
- G
- GANCICLOVIR SODIUM
- GALLIUM NITRATE
- GALSULFASE
- GEMCITABINE HYDROCHLORIDE
- GENTAMICIN SULFATE
- GLUCAGON
- GLUCARPIDASE
- GLYCOPYRROLATE
- GOLIMUMAB
- GRANISETRON HYDROCHLORIDE
- GENERIC DRUGS: H
- H
- HEMIN
- HEPARIN SODIUM
- HEPATITIS B IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
- HETASTARCH
- HYDRALAZINE HYDROCHLORIDE
- HYDROCORTISONE SODIUM SUCCINATE
- HYDROMORPHONE HYDROCHLORIDE
- HYDROXOCOBALAMIN
- 6% HYDROXYETHYL STARCH 130/0.4 IN 0.9% SODIUM CHLORIDE INJECTION
- GENERIC DRUGS: I
- I
- IBALIZUMAB-uiyk
- IBANDRONATE SODIUM
- IBUPROFEN
- IBUPROFEN LYSINE
- IBUTILIDE FUMARATE
- IDARUBICIN HYDROCHLORIDE
- IDARUCIZUMAB
- IDURSULFASE
- IFOSFAMIDE
- IMIGLUCERASE ■ VELAGLUCERASE ALFA
- IMIPENEM-CILASTATIN
- IMIPENEM, CILASTATIN, AND RELEBACTAM
- IMMUNE GLOBULIN INTRAVENOUS
- INDOMETHACIN SODIUM
- INFLIXIMAB ■ INFLIXIMAB-dyyb ■ INFLIXIMAB-abda ■ INFLIXIMAB-axxq ■ INFLIXIMAB-qbtx
- INOTUZUMAB OZOGAMICIN
- INSULIN HUMAN INJECTION (REGULAR)
- INTERFERON ALFA-2b, RECOMBINANT
- IPILIMUMAB
- IRINOTECAN HYDROCHLORIDE ■ IRINOTECAN LIPOSOME INJECTION
- IRON DEXTRAN INJECTION
- IRON SUCROSE
- ISATUXIMAB
- ISAVUCONAZONIUM SULFATE
- ISOPROTERENOL HYDROCHLORIDE
- IXABEPILONE
- GENERIC DRUGS: K
- K
- KETOROLAC TROMETHAMINE
- GENERIC DRUGS: L
- L
- LABETALOL HYDROCHLORIDE
- LACOSAMIDE
- LARONIDASE
- LEFAMULIN
- LETERMOVIR
- LEUCOVORIN CALCIUM
- LEVETIRACETAM INJECTION
- LEVOCARNITINE
- LEVOFLOXACIN
- LEVOTHYROXINE SODIUM
- LIDOCAINE HYDROCHLORIDE
- LINCOMYCIN HYDROCHLORIDE
- LINEZOLID
- LIOTHYRONINE SODIUM
- LORAZEPAM
- LYMPHOCYTE IMMUNE GLOBULIN
- GENERIC DRUGS: M
- M
- MAGNESIUM SULFATE
- MANNITOL
- MECHLORETHAMINE HYDROCHLORIDE
- MELOXICAM INJECTION
- MEPERIDINE HYDROCHLORIDE
- MEROPENEM
- MEROPENEM AND VABORBACTAM FOR INJECTION
- MESNA
- METHADONE HYDROCHLORIDE
- METHOCARBAMOL
- METHOTREXATE SODIUM
- METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA
- METHYLENE BLUE
- METHYLERGONOVINE MALEATE
- METHYLPREDNISOLONE SODIUM SUCCINATE
- METOCLOPRAMIDE HYDROCHLORIDE
- METOPROLOL TARTRATE
- METRONIDAZOLE HYDROCHLORIDE
- MICAFUNGIN SODIUM
- MILRINONE LACTATE
- MINOCYCLINE HYDROCHLORIDE
- MITOMYCIN
- MITOXANTRONE HYDROCHLORIDE
- MOGAMULIZUMAB-kpkc
- MORPHINE SULFATE
- MOXIFLOXACIN HYDROCHLORIDE
- MULTIVITAMIN INFUSION
- MYCOPHENOLATE MOFETIL HYDROCHLORIDE
- GENERIC DRUGS: N
- N
- NAFCILLIN SODIUM
- NALBUPHINE HYDROCHLORIDE
- NALOXONE HYDROCHLORIDE
- NATALIZUMAB
- NECITUMUMAB
- NEOSTIGMINE METHYLSULFATE
- NICARDIPINE HYDROCHLORIDE
- NITROGLYCERIN IV
- NITROPRUSSIDE SODIUM
- NIVOLUMAB
- NIVOLUMAB AND RELATLIMAB
- NOREPINEPHRINE BITARTRATE
- GENERIC DRUGS: O
- O
- OBINUTUZUMAB
- OBILTOXAXIMAB
- OCRELIZUMAB
- OCTREOTIDE ACETATE
- OFATUMUMAB
- OLARATUMAB
- OMADACYCLINE
- ONDANSETRON HYDROCHLORIDE
- ORITAVANCIN
- ORPHENADRINE CITRATE
- OXACILLIN SODIUM
- OXALIPLATIN
- OXYTOCIN INJECTION
- GENERIC DRUGS: P
- P
- PACLITAXEL ■ PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND)
- PALIFERMIN
- PALONOSETRON
- PAMIDRONATE DISODIUM
- PANITUMUMAB
- PANTOPRAZOLE SODIUM
- PAPAVERINE HYDROCHLORIDE
- PARICALCITOL
- PEGASPARGASE ■ ASPARAGINASE Erwinia chrysanthemi
- PEGLOTICASE
- PEMBROLIZUMAB
- PEMETREXED
- PENICILLIN G AQUEOUS
- PENTAMIDINE ISETHIONATE
- PENTETATE CALCIUM TRISODIUM INJECTION ■ PENTETATE ZINC TRISODIUM INJECTION
- PENTOBARBITAL SODIUM
- PENTOSTATIN
- PERAMIVIR
- PERTUZUMAB
- PHENOBARBITAL SODIUM
- PHENTOLAMINE MESYLATE
- PHENYLEPHRINE HYDROCHLORIDE
- PHENYTOIN SODIUM
- PHOSPHATE
- PHYSOSTIGMINE SALICYLATE
- PHYTONADIONE
- PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM
- PLASMA PROTEIN FRACTION
- POLATUZUMAB VEDOTIN-piiq
- POOLED PLASMA (HUMAN)
- PORFIMER SODIUM
- POSACONAZOLE
- POTASSIUM ACETATE AND POTASSIUM CHLORIDE
- PRALATREXATE
- PRALIDOXIME CHLORIDE
- PROCAINAMIDE HYDROCHLORIDE
- PROCHLORPERAZINE EDISYLATE
- PROMETHAZINE HYDROCHLORIDE
- PROPOFOL INJECTION
- PROPRANOLOL HYDROCHLORIDE
- PROTAMINE SULFATE
- PROTEIN AMINO ACIDS, DEXTROSE, FAT EMULSION, AND ELECTROLYTES
- PROTEIN (AMINO ACID) PRODUCTS
- PROTEIN C CONCENTRATE (HUMAN)
- PROTHROMBIN COMPLEX CONCENTRATE (HUMAN)
- PYRIDOSTIGMINE BROMIDE
- PYRIDOXINE HYDROCHLORIDE
- GENERIC DRUGS: R
- R
- RASBURICASE
- RAVULIZUMAB-cwvz
- RAXIBACUMAB
- REGADENOSON
- REMDESIVIR
- REMIFENTANIL HYDROCHLORIDE
- RESLIZUMAB
- RETEPLASE RECOMBINANT
- Rho(D) IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
- RIFAMPIN
- RITUXIMAB ■ RITUXIMAB-abbs ■ RITUXIMAB-pvvr ■ RITUXIMAB-arrx
- ROCURONIUM BROMIDE
- ROMIDEPSIN
- GENERIC DRUGS: S
- S
- SACITUZUMAB GOVITECAN
- SARGRAMOSTIM
- SEBELIPASE ALFA
- SECRETIN (HUMAN) ■ SECRETIN (PORCINE)
- SERMORELIN ACETATE
- SILDENAFIL
- SILTUXIMAB
- SINCALIDE
- SIPULEUCEL-T
- SODIUM ACETATE
- SODIUM BICARBONATE
- SODIUM CHLORIDE
- SODIUM FERRIC GLUCONATE COMPLEX
- SODIUM THIOSULFATE
- SODIUM LACTATE
- SODIUM NITRITE AND SODIUM THIOSULFATE
- SODIUM PHENYLACETATE AND SODIUM BENZOATE
- SOTALOL HYDROCHLORIDE
- STREPTOMYCIN SULFATE
- STREPTOZOCIN
- SUCCINYLCHOLINE CHLORIDE
- SUGAMMADEX
- SULFAMETHOXAZOLE AND TRIMETHOPRIM
- GENERIC DRUGS: T
- T
- TACROLIMUS
- TAGRAXOFUSP-erzs
- TALIGLUCERASE ALFA
- TEDIZOLID PHOSPHATE
- TELAVANCIN
- TEMOZOLOMIDE
- TEMSIROLIMUS
- TENECTEPLASE
- TENIPOSIDE
- THEOPHYLLINE IN D5W
- TERLIPRESSIN
- THIAMINE HYDROCHLORIDE
- THIOTEPA
- TIGECYCLINE FOR INJECTION
- TIROFIBAN HYDROCHLORIDE
- TISAGENLECLEUCEL
- TOBRAMYCIN SULFATE
- TOCILIZUMAB
- TOPOTECAN HYDROCHLORIDE
- TRABECTEDIN
- TRACE METALS
- TRANEXAMIC ACID
- TRASTUZUMAB ■ TRASTUZUMAB-dkst ■ TRASTUZUMAB-dttb ■ TRASTUZUMAB-pkrb ■ TRASTUZUMAB-anns ■ TRASTUZUMAB-qyyp
- TREPROSTINIL
- TRILACICLIB
- GENERIC DRUGS: V
- V
- VACCINIA IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
- VALPROATE SODIUM
- VANCOMYCIN HYDROCHLORIDE
- VASOPRESSIN INJECTION
- VECURONIUM BROMIDE
- VEDOLIZUMAB
- VERAPAMIL HYDROCHLORIDE
- VERTEPORFIN
- VESTRONIDASE ALFA-vjbk INJECTION
- VINBLASTINE SULFATE
- VINCRISTINE SULFATE ■ VINCRISTINE SULFATE LIPOSOME INJECTION
- VINORELBINE
- VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN)
- VON WILLEBRAND FACTOR (RECOMBINANT)
- VORICONAZOLE
- GENERIC DRUGS: Z
- Z
- ZIDOVUDINE
- ZIV-AFLIBERCEPT
- ZOLEDRONIC ACID
- APPENDIX A: Recommendations for the Safe Use and Handling of Cytotoxic Drugs
- APPENDIX B: FDA Pregnancy Categories
- APPENDIX C: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE)
- APPENDIX D: Information for Patients Receiving Immunosuppressive Agents
- APPENDIX E: Recently Approved Drugs
- INDEX
- Solution Compatibility Chart
- No. of pages: 1344
- Language: English
- Edition: 41
- Published: August 24, 2024
- Imprint: Elsevier
- formats.SpiralBound ISBN: 9780443120404
- eBook ISBN: 9780443120992
SC
Shelly Rainforth Collins
Shelly Collins, PharmD, has decades of clinical experience in which she has been responsible for overseeing system-wide pharmaceutical safety.
Affiliations and expertise
President, Drug Information Consultants, Chesapeake, Virginia, USA